Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128961 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL128669 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL128196 | 1.00 | — | — | |
| SCHEMBL1274555 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL1275460 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL128011 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL141691 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL20503206 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL20503190 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL126569 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115702231-A | Additives or compositions for imparting lubricity | 三吉油脂株式会社 | 2023-02-14 | — | — | CN | disclosed |
| US-11548910-B2 | Oligonucleotide production method | NISSAN CHEMICAL CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| EP-3082171-B1 | COMPOSITION FOR ANODE BUFFER LAYER OF ORGANIC THIN FILM SOLAR CELL AND ORGANIC THIN FILM SOLAR CELL | NISSAN CHEMICAL CORP (JP) | 2022-04-27 | — | — | EP | disclosed |
| CN-113490710-A | Polycarbonate resin composition | 帝人株式会社 | 2021-10-08 | — | — | CN | disclosed |
| US-10562919-B2 | Complex and process for preparing complex | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| EP-2759574-B1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL CORP (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-10322317-B2 | Rubber composition, crosslinked rubber molded product and golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2019-06-18 | — | — | US | disclosed |
| US-20190169223-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2019-06-06 | — | — | US | disclosed |
| US-10293215-B2 | Rubber composition, crosslinked rubber molded product and golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2019-05-21 | — | — | US | disclosed |
| US-20180311622-A1 | PURIFICATION METHOD FOR PURIFYING LIQUID, PURIFICATION METHOD FOR PURIFYING SILICON COMPOUND-CONTAINING LIQUID, METHOD FOR PRODUCING SILYLATING AGENT LIQUID, FILM FORMING MATERIAL OR DIFFUSING AGENT COMPOSITION, FILTER MEDIUM AND FILTER DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-11-01 | — | — | US | disclosed |
| US-20080058526-A1 | Halogenation of Rylen-Carboximides with Elementary Halogene in a Two-Phase Mixture Comprising an Organic Solvent and Water, Wherein Formed Halogene Hydrocide is Continously Removable from the Organic Solvent | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-06 | — | — | US | disclosed |
| WO-2007128774-A1 | METHOD FOR PRODUCING ORGANIC FIELD-EFFECT TRANSISTORS | BASF SE (DE) | 2007-11-15 | — | — | WO | disclosed |
| US-20070191468-A1 | Amino alcohol compound | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1505098-B1 | FLUORINE-CONTAINING WATER-SOLUBLE NONIONIC SURFACE -ACTIVE COMPOUNDS, USE THEREOF AND PROCESS FOR PREPARATION OF THE COMPOUNDS | DAIKIN IND LTD (JP) | 2007-01-17 | — | — | EP | disclosed |
| EP-1733724-A1 | AMINO ALCOHOL COMPOUND | Sankyo Company, Limited (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-20050170989-A1 | Fluorine-containing water-soluble nonionic surface-active compounds, use thereof and process for preparation of the compounds | DAIKIN INDUSTRIES, LTD. (JP) | 2005-08-04 | — | — | US | disclosed |
| EP-1505098-A1 | FLUORINE-CONTAINING WATER-SOLUBLE NONIONIC SURFACE -ACTIVE COMPOUNDS, USE THEREOF AND PROCESS FOR PREPARATION OF THE COMPOUNDS | Daikin Industries, Ltd. (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-4889953-A | ANTITUMOR AND -CARCINOGENIC AGENTS; PLATELET ACTIVATING FACTOR ANTAGONIST; CARDIOVASCULAR DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-12-26 | — | — | US | disclosed |
| EP-0304244-A2 | Propanediol derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1989-02-22 | — | — | EP | disclosed |
| EP-0254540-A2 | Glycerol derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1988-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058526-A1 | Halogenation of Rylen-Carboximides with Elementary Halogene in a Two-Phase Mixture Comprising an Organic Solvent and Water, Wherein Formed Halogene Hydrocide is Continously Removable from the Organic Solvent | CYP8B1, HACL2, CTRB2 | CYP1A2 79/4885CYP2D6 596/4885MAPT 4697/4885 |
| US-10293215-B2 | Rubber composition, crosslinked rubber molded product and golf ball | GIGYF2, RACK1, COG1 | CYP1A2 464/4885CYP2D6 2668/4885MAPT 3275/4885 |
| US-11548910-B2 | Oligonucleotide production method | RNGTT, OSGEP, PHAX | CYP1A2 4134/4885CYP2D6 2610/4885MAPT 3183/4885 |
| US-20190169223-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | RNGTT, OSGEP, PHAX | CYP1A2 4134/4885CYP2D6 2610/4885MAPT 3183/4885 |
| US-20070191468-A1 | Amino alcohol compound | ADH1A, ADH1C, BCAT1 | CYP1A2 87/4885CYP2D6 115/4885MAPT 2680/4885 |
| US-10562919-B2 | Complex and process for preparing complex | SCO2, AP1M1, AP3M1 | CYP1A2 899/4885CYP2D6 1086/4885MAPT 4184/4885 |
| US-20180311622-A1 | PURIFICATION METHOD FOR PURIFYING LIQUID, PURIFICATION METHOD FOR PURIFYING SILICON COMPOUND-CONTAINING LIQUID, METHOD FOR PRODUCING SILYLATING AGENT LIQUID, FILM FORMING MATERIAL OR DIFFUSING AGENT COMPOSITION, FILTER MEDIUM AND FILTER DEVICE | STOM, MLST8, SI | CYP1A2 2969/4885CYP2D6 4375/4885MAPT 2680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.